PRAMEF11

mutation — cross-omics
Cross-omicsMUTATION → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, PRAMEF11 mutation is significantly associated with the RNA expression of many other genes, with 3,491 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible PRAMEF11-associated genes across cancer lineages are FANCG, PHC2-AS1, and EEF1E1-BLOC1S5. Each is linked with PRAMEF11 in more than 2 cancer types. Because this analysis shows association rather than direction, both PRAMEF11-to-partner and partner-to-PRAMEF11 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, FANCG grouped by PRAMEF11-low versus PRAMEF11-high in UCEC.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (PRAMEF11→partner) and Y-score (partner→PRAMEF11) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
UCECFANCG →+0.626+2.815<.001.00133
UCECPHC2-AS1 →+0.368+3.733.001.00133
CESCEEF1E1-BLOC1S5 →+0.042+4.969<.001.00433
LUADMAGEA2B →+0.106+2.948.002.00533
LUADLINC02163 →+1.482+3.430<.001.00933
SKCMKIFC1 →+0.451+1.864.001<.00133
Each partner links to its Q-omics profile. Showing the 6 strongest of 3,491 associations by consensus.

FANCG by PRAMEF11 expression — UCEC

Box plot of FANCG in PRAMEF11-low vs PRAMEF11-high samples in UCEC.

Explore this box plot interactively →

Exploration